HER2 POSITIVE BREAST CANCER

This adverse event was reported 86 times

These drugs are most commonly taken by patients reporting HER2 POSITIVE BREAST CANCER:

# Drug Count
0 TRASTUZUMAB 38
1 PERTUZUMAB 25
2 DOCETAXEL 23
3 DOCETAXEL ANHYDROUS 23
4 PACLITAXEL 17
5 CYCLOPHOSPHAMIDE 13
6 ANASTROZOLE 8
7 ANASTROZOLE TABLETS 8
8 APIXABAN 8
9 CAPECITABINE 8
See all common drugs associated with HER2 POSITIVE BREAST CANCER

HER2 POSITIVE BREAST CANCER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF 1 0.0101
1 NERATINIB 6 0.0034
2 FOSNETUPITANT AND PALONOSETRON 2 0.0030
3 ERIBULIN MESYLATE 6 0.0022
4 PERTUZUMAB 25 0.0016
5 ANTISEPTIC SKIN CLEANSER 5 0.0016
6 TRANEXAMIC ACID 6 0.0012
7 ADO-TRASTUZUMAB EMTANSINE 5 0.0012
8 CHLORHEXIDINE GLUCONATE 5 0.0011
9 ERTAPENEM SODIUM 5 0.0010
See all drugs enriched for association with HER2 POSITIVE BREAST CANCER

HER2 POSITIVE BREAST CANCER is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Monobactam Antibacterial [EPC] 6 0.0031
1 Antifibrinolytic Agent [EPC] 6 0.0010
2 HER2/neu Receptor Antagonist [EPC] 41 0.0008
3 Vitamin K [EPC] 5 0.0008
4 Endoglycosidase [EPC] 1 0.0007
5 Microtubule Inhibitor [EPC] 27 0.0003
6 Aromatase Inhibitor [EPC] 17 0.0002
7 Estrogen Receptor Antagonist [EPC] 4 0.0002
8 Aminoglycoside Antibacterial [EPC] 6 0.0002
9 Histamine-1 Receptor Antagonist [EPC] 6 0.0002
See all drug classes enriched for association with HER2 POSITIVE BREAST CANCER